|
It was reported a single use implantable drug delivery device with a port needle was connected to the patient on (b)(6).On (b)(6), during an infusion, fluid leakage was detected at the connection point between the port needle and the tubing; a new port needle was replaced and used for puncture.
|
|
H11: section a through f, the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The device has not been received by the manufacturer for evaluation.Each event reported to bd is evaluated and investigated in accordance with our complaint investigation procedures.The investigation process includes, but is not limited to, evaluation of the event details provided by the complaint facility, a review of complaint history, manufacturing records and risk document where applicable, and an evaluation of the subject device when available to identify potential contributing factors.
|